Jane Henderson Akero Therapeutics, Inc. (AKRO) insider trading activity

AKRO Quotes by TradingView

Jane Henderson is of Akero Therapeutics, Inc.. Currently has a direct ownership of 0 shares of AKRO, which is worth approximately $0. The most recent transaction as insider was on Jun 16, 2023, when has been sold 40,000 shares (Common Stock) at a price of $54.13 per share, resulting in proceeds of $2,165,200. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
0% 12M change
Total Value Held $0

Jane Henderson Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 16 2023
SELL
Open market or private sale
$2,165,200 $54.13 p/Share
40,000 Reduced 100.0%
0 Common Stock
Jun 16 2023
BUY
Exercise of conversion of derivative security
$280,400 $7.01 p/Share
40,000 Added 50.0%
40,000 Common Stock

Also insider at

SESN
Sesen Bio, Inc. Healthcare
Director
ISEE
IVERIC bio, Inc. Healthcare
Director
ADGI
Adagio Therapeutics, Inc. Healthcare
Chief Financial Officer
APGE
Apogee Therapeutics, Inc.
Chief Financial Officer
CRGX
CARGO Therapeutics, Inc.
JH

Jane Henderson

Parsippany, NJ

Track Institutional and Insider Activities on AKRO

Follow Akero Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AKRO shares.

Notify only if

Insider Trading

Get notified when an Akero Therapeutics, Inc. insider buys or sells AKRO shares.

Notify only if

News

Receive news related to Akero Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on AKRO